000028.SZ
国药一致
SZSE · Healthcare · F 批发零售 · CN
CNY 19.59
+0.62%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 72.9B | 73.4B | 74.4B | 75.5B | 73.4B |
| Cost of Revenue | 65.2B | 65.6B | 66.1B | 66.4B | 64.5B |
| Gross Profit | 7.7B | 7.8B | 8.2B | 9.1B | 8.9B |
| Operating Expenses | |||||
| R&D Expense | 15.6M | 20.0M | 24.6M | 26.8M | 9.1M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 1.0B | 1.0B | 1.1B | 1.1B | 1.1B |
| Selling & Marketing Expense | 4.7B | 4.8B | 5.4B | 5.3B | 5.3B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 6.1B | 6.2B | 6.9B | 6.9B | 6.8B |
| Cost and Expenses | 71.4B | 71.8B | 73.0B | 73.3B | 71.3B |
| Operating Income (EBIT) | 1.5B | 1.5B | 573.5M | 2.5B | 2.3B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 1.4B | 1.5B | 575.5M | 2.5B | 2.3B |
| Income Tax Expense | 361.7M | 380.7M | 338.5M | 514.7M | 539.3M |
| Bottom Line | |||||
| Net Income | 1.1B | 1.1B | 642.5M | 1.6B | 1.5B |
| Earnings from Cont. Ops | 1.1B | 1.1B | 237.0M | 2.0B | 1.8B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.1B | 1.1B | 642.5M | 1.6B | 1.5B |
| Per Share | |||||
| Basic EPS | CN¥1.97 | CN¥2.04 | CN¥1.15 | CN¥2.87 | CN¥2.67 |
| Diluted EPS | CN¥1.97 | CN¥2.04 | CN¥1.15 | CN¥2.87 | CN¥2.67 |
| Revenue Per Share | CN¥131.95 | CN¥131.85 | CN¥133.13 | CN¥135.45 | CN¥131.90 |
| Shares | |||||
| Basic Shares Outstanding | 552.8M | 556.8M | 558.7M | 557.2M | 556.8M |
| Diluted Shares Outstanding | 552.8M | 556.8M | 558.7M | 557.2M | 556.8M |
| Profitability Metrics | |||||
| EBITDA | — | 2.9B | 2.3B | 4.1B | 2.7B |
| D&A | — | 1.4B | 1.7B | 1.6B | 424.6M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026